Individualizing infertility therapy with pharmacogenomics: Vanity or vanguard?

Pharmacogenomics

Volumn 9, Issue 9, 2008, Pages 1179-1181

  Legro, Richard S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CLOMIFENE; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; DNA; ESTROGEN RECEPTOR ALPHA; FOLLITROPIN RECEPTOR; GONADOTROPIN; METFORMIN; PROTEIN SERINE THREONINE KINASE;

BODY WEIGHT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DNA DETERMINATION; DRUG TARGETING; EDITORIAL; FEMALE INFERTILITY; GENETIC POLYMORPHISM; HUMAN; INDIVIDUALIZATION; INFERTILITY THERAPY; MALE INFERTILITY; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MONOTHERAPY; MULTIPLE PREGNANCY; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PHARMACOGENETICS; PHARMACOGENOMICS; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PREMATURITY; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT FAILURE;

FEMALE; GENETIC VARIATION; HUMANS; INFERTILITY, FEMALE; PHARMACOGENETICS;

EID: 55449117651     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.9.9.1179     Document Type: Editorial

References (7)

1. Schwarz UI, Ritchie MD, Bradford Y et al.: Genetic determinants of response to warfarin during initial anticoagulation. N. Engl. J. Med. 358, 999-1008 (2008).
2. Mallal S, Phillips E, Carosi G et al.: HLA-B*5701 screening for hypersensitivity to abacavir. N. Engl. J. Med. 358, 568-579 (2008).
3. Lu E, Barfield WD, Wilber N, Diop H, Manning SE, Fogerty S: Surveillance of births conceived with various infertility therapies in Massachusetts, January-March 2005. Public Health Rep. 123, 173-177 (2008).
4. Greb RR, Behre HM, Simoni M: Pharmacogenetics in ovarian stimulation - current concepts and future options. Reprod. Biomed. Online 11, 589-600 (2005).
5. Legro RS, Barnhart HX, Schlaff WD et al.: Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 356, 551-566 (2007).
6. Legro RS, Barnhart HX, Schlaff WD et al.: Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene. J. Clin. Endocrinol. Metab. 93, 792-800 (2008).
7. Legro RS, Myers E: Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Hum. Reprod. 19, 1697-1704 (2004).